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Abstract
Objective—Chorea-acanthocytosis (ChAc) is an uncommon autosomal recessive disorder due to
mutations of the VPS13A gene, which encodes for the membrane protein chorein. ChAc presents
with progressive limb and orobuccal chorea, but there is often a marked dysexecutive syndrome.
ChAc may first present with neuropsychiatric disturbance such as obsessive-compulsive disorder
(OCD), suggesting a particular role for disruption to striatal structures involved in non-motor
frontostriatal loops, such as the head of the caudate nucleus. Two previous studies have suggested
a marked reduction in volume in the caudate nucleus and putamen, but did not examine
morphometric change.
Methods—We investigated morphometric change in 13 patients with genetically or
biochemically confirmed ChAc and 26 age- and gender-matched controls. Subjects underwent
magnetic resonance imaging and manual segmentation of the caudate nucleus and putamen, and
shape analysis using a non-parametric spherical harmonic technique.
Results—Both structures showed significant and marked reductions in volume compared to
controls, with reduction greatest in the caudate nucleus. Both structures showed significant shape
differences, particularly in the head of the caudate nucleus. No significant correlation was shown
between duration of illness and striatal volume or shape, suggesting that much structural change
may have already taken place at the time of symptom onset.
Conclusions—Our results suggest that striatal neuron loss may occur early in the disease
process, and follows a dorsal-ventral gradient that may correlate with early neuropsychiatric and
cognitive presentations of the disease.
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INTRODUCTION
The neuroacanthocytoses are a group of disorders that present with neurological and
psychiatric manifestations, and acanthocytes, spiculated red blood cells. Chorea-
acanthocytosis (ChAc; MIM 200150) is an autosomal recessive disorder associated with
mutations or deletions in the VPS13A gene on chromosome 9q. This gene codes for the
membrane protein chorein(Rampoldi et al. 2002; Ueno et al. 2001), which is strongly
expressed in the brain(Dobson-Stone et al. 2002). Loss of function of chorein appears to
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affect basal ganglia neurons, especially those in the caudate and putamen(Bader et al. 2008).
Onset of neurological disturbance in ChAc is usually between ages 25 and 45, commonly
with limb chorea that may be indistinguishable from Huntington’s disease(Dobson-Stone et
al. 2002), but also with distinctive lingual feeding dystonia(Bader et al. 2010). Identification
and sequencing of the VPS13A gene(Rampoldi et al. 2001; Ueno et al. 2001) has enabled
definitive diagnosis of ChAc and differentiation from related neuroacanthocytosis
syndromes such as McLeod syndrome(Danek et al. 2005). Diagnosis has been facilitated by
the development of a Western blot screening test for decreased or absent levels of
chorein(Dobson-Stone et al. 2004).
Histopathologically, the relatively limited number of ChAc cases with confirmed VPS13A
mutations have shown marked striatal neuronal loss with reactive astrocytic gliosis,
particularly in the head of the caudate nucleus, with the globus pallidus less affected; and
with minimal changes in the thalamus and substantia nigra, with the cortex almost
universally spared(Bader et al. 2008). Magnetic resonance imaging (MRI) findings in
established ChAc cases mirror these findings, showing marked striatal atrophy in the
absence of significant cortical atrophy(Hardie et al. 1991; Kutcher et al. 1999; Walterfang et
al. 2008).
The functional consequences of these changes in the striatum are the relatively characteristic
choreiform movements, thought to be the result of disruption of motor loops in the putamen
and pallidum(Danek et al. 2005), and behavioural and neuropsychiatric symptoms. The
involvement of non-motor frontostriatal loops that run through the caudate nucleus in
particular may be responsible for the characteristic executive impairment seen in the
illness(Danek et al. 2005; Hardie et al. 1991). Patients with ChAc have very high rates of
obsessive-compulsive disorder(Walterfang et al. 2008), unique for any neurodegenerative
condition, suggesting that disruption to the caudate’s central role in the function of the
lateral orbitofrontal loop (LOFL) in subserving the choice of behavioural actions relevant to
emotional and cognitive inputs from frontal cortex(Chamberlain et al. 2005).
Aside from case reports, only two systematic analyses of striatal volume have been
undertaken in ChAc patients. Henkel et al. used a voxel-based morphometry (VBM)
approach to compare 6 ChAc patients to 15 age-matched controls, and showed a focal and
symmetrical atrophy of the caudate nucleus, but no reduction in any other brain region,
including in the putamen(Henkel et al. 2006). Huppertz et al. expanded this dataset to 9
ChAc patients, and utilised the normalization component of the VBM approach of Henkel et
al. to create caudate and putamen masks from a large control group average to determine
normalized volume of these structures. They demonstrated a significant volumetric
reduction in both structures, and showed complete separation of ChAc patients and controls
on measures of caudate volume(Huppertz et al. 2008). However, the methodology of these
studies did not extend beyond analysing the total volume of striatal structures in ChAc. One
study analysed striatal volume in three brothers with McLeod syndrome (a related
neuroacanthocytosis syndrome) and 20 matched controls, and showed that patients’ striatal
volumes were significantly reduced compared to controls, with caudate nuclei showing a
trend towards significant volume reduction over a seven-year follow-up period (Valko et al.
2010).
We sought to confirm and extend upon the findings of Huppertz et al. (2008) with an
expanded dataset, using a standardized and validated traditional manual tracing
methodology for each structure, followed by a morphometric analysis to determine whether
the shape or morphology of the caudate and putamen differed between ChAc patients and
controls. This allowed us to explore whether there are regional neuroanatomical changes to
striatal structures in ChAc that may relate to the characteristic symptoms of the illness. Our
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hypothesis was that the caudate nucleus would be disproportionately affected, and that we
would find a predilection for involvement of the head of the caudate nucleus, in particular
regions that form a crucial component of the LOFL, in the patient group.
2. MATERIALS AND METHODS
2.1 Subjects
Patients with ChAc (n=13) were recruited from multiple centres worldwide, including the
United Kingdom, Europe, North and South America, and Australia. Patients 1–8 include the
6 patients described in the previously described VBM study (Henkel et al. 2006) and
patients 1–7 reported by (Huppertz et al. 2008). Patient 9 has been previously clinically
described (Robertson et al. 2008; Walterfang et al. 2008) and patient 11 corresponds to case
2 of (Rodrigues et al. 2008). Patients 12 & 13 are two previously unpublished siblings from
Australia. Molecular genetic diagnosis was confirmed by mutations in the VPS13A gene,
abnormally reduced chorein expression by Western blot, or both. 4/13 patients had
obsessive-compulsive symptoms or disorder, and 11/13 had executive dysfunction. Controls
(n=26) were matched two-for-one for age and gender to the patient sample, and were
selected from a large database of healthy normal controls recruited by hospital and media
advertisements by the Melbourne Neuropsychiatry Centre.
2.2 MRI scanning
High-resolution volume-rendering 3D datasets of the whole head were obtained for all
subjects for the purpose of manual volumetry. All control subjects were scanned on a 1.5T
General Electric Signa MRI scanner (GE, Milwaukee, USA) at the Royal Melbourne
Hospital, Melbourne. Images were acquired in the axial plane using a T1 weighted, 3D
Spoiled Gradient Recalled Echo (SPGR) protocol (slice thickness=1.5mm, in plane
resolution=0.9375mm×0.9375mm). ChAc subjects 1–9 were also scanned on a 1.5T General
Electric Signa scanner, using a similar SPGR sequence; patient 10 was scanned on a 1.5T
Siemens Magnetom Vision Plus and patients 11–13 on a 1.5T Siemens Avanto, using a T1
weighted, 3D Magnetized Prepared RApid Gradient Echo (MPRAGE) protocol (slice
thickness=1mm, in plane resolution=1mm×1mm). As ChAc patients were scanned on
different machines, the signal-to-noise ratio (SNR) was calculated for each scan using
regions-of-interest in left prefrontal white matter (WM) and in the image background (BG).
SNR was calculated as mean of the WM signal divided by the standard deviation of the BG
signal. The SNR between controls (0.0447±0.0123) and ChAc patients (0.0509±0.0246) was
not significantly different (p=0.307).
2.3 Image Processing
Images were transferred to an Intel Apple MacBook Pro computer running OSX 10.5 (Apple
Inc, Cupertino, USA), and were checked manually for gross structural abnormalities prior to
analysis. The software ANALYZE 9.0 (Mayo BIR, Rochester, NY, USA) was used for
image analysis. Images were rescaled to isotropic format (1x1x1mm3). Manual
segmentation was axially performed using a standardized view, rigidly aligned in the AC-PC
plane. All brain scans were analysed blindly to all clinical information by an experienced
rater (JCLL, figure 1). A standardized manual tracing protocol was used to trace and
quantify the volume of the caudate via tracing its axial outline serially through successive
images (Looi et al. 2008). Intra-rater class correlation was established at 0.97 for this rater
(Looi et al. 2008). We then adapted a reference image-based protocol developed previously
for a study of the putamen in frontotemporal lobar degeneration (Looi et al. 2009). Intra-
rater class correlation was 0.93 for this rater (Looi et al. 2009). Inter-rater reliability with
another experienced tracer using this method was rated at 0.98 for the caudate and 0.87 for
the putamen (Looi et al. 2008; Looi et al. 2009). Volumes obtained were normalized in
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relevant analyses by calculation of total intracranial volume (ICV). We then calculated Z-
scores for all subjects based on the mean and standard deviation volume measures from the
control group, as in a previous analysis of ChAc patients (Huppertz et al. 2008). Total ICV
was measured by a stereological point counting technique manually tracing the intracranial
volume, with every fourth slice traced. The starting point was randomly chosen from the
most anterior four brain slices. The landmarks for delineation and protocol are based upon
those previously published (Eritaia et al. 2000).
2.4 Shape Analysis
Shape analysis was undertaken in a semi-automated fashion using the University of North
Carolina shape analysis toolkit (Paniagua et al. 2009; Styner et al. 2006), and which has
been used in a range of studies in neuropsychiatric illness (Levitt et al. 2009; Styner et al.
2004; Zhao et al. 2008). Segmented 3D label maps are initially processed to ensure interior
holes are filled, followed by morphological closing and minimal smoothing. These are then
subjected to spherical harmonic shape description (SPHARM-PDM), with reconstructed
boundary surfaces of all segmentations mapped onto the unit sphere and described via a set
of coefficients weighting spherical harmonic basis functions. The correspondence between
surfaces is established by a parameter-based rotation based on first-order expansion of the
spherical harmonics. All surfaces are then uniformly sampled into sets of 1002 surface
points each. These surfaces are then aligned to a study-averaged template for each structure
(left and right caudate and putamen) using rigid-body Procrustes alignment (Bookstein
1997), with normalization for head size corrected for using ICV via a scaling factor, fi,
where fi = (Mean (ICV)/ICVi)1/3.
2.5 Statistical Analysis
Analysis for between-group differences in continuous demographic variables was
undertaken with independent t-tests. Individual striatal volumes were compared using
analysis of covariance (ANCOVA), covarying for ICV. To analyze a differential effect of
side (left and right) and structure (caudate and putamen) between groups, we undertook a
repeated-measures analysis of covariance (RM-ANCOVA) using side and structure as
within-subject factors, covarying for ICV. To examine the effect of duration of illness, we
examined Spearman’s correlation co-efficient. To compare structural shape between ChAc
patients and controls, we computed the local Hotelling T2 two-sample mean difference, and
corrected for multiple comparisons using false discovery rate (FDR) (Genovese et al. 2002).
We generated mean difference magnitude displacement maps and significance maps of the
local p-values in raw format, and corrected for multiple comparisons. We also computed an
overall, global shape difference summarizing the group differences across surface maps via
averaging. Correlation with illness variables were performed locally based on Spearman’s
rank-order correlation of the projection of the surface points onto the group average surface
normal. Raw and corrected p-values were calculated as per group differences, and
displacement and significance maps were generated.
3. RESULTS
3.1 Demographic and symptom data
The characteristics of the patient group is presented in table 1, and between-group
comparisons of demographic and volumetric data in table 2. The patient group was not
significantly different in age (t=−0.418, p=0.680) and was identical in gender mix. The
mean duration of illness in the patient group was 12.57±6.87 years.
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Whilst ICV was 9% smaller in the ChAc group, this was not significant (t=−1.692,
p=0.107). However, individual striatal structures were all significantly smaller in the ChAc
group, by 55–60% (figures 2 and 3, table 2). All structures were significant at p<0.0001. A
Z-score of −2 separated all ChAc patients from controls at the caudate level, and all but
patients 12 & 13, two sisters, in the putamen. RM-ANCOVA showed a main effect of group
(p<0.0001) and a structure-by-group interaction (F=7.735, p<0.01), but no side-by-group
(F=0.038, p=0.845), structure-by-side (F=0.161, p=0.691) or structure-by-side-by-group
interaction (F=0.043, p=0.846). There were no significant correlations between duration of
illness and left (r=−0.190, p=0.950) or right (r=−0.036, p=0.950) caudate volume, nor for
left (r=−0.157, p=0.608) or right (r=−0.246, p=0.419) putamen volume. There was no effect
of scanner type (GE vs Siemens) on volume.
3.3 Shape analysis
Shape analysis demonstrated significant changes in both structures. An overall shape
difference between groups was shown for the left caudate (p<0.0001), right caudate
(p<0.0001), left putamen (p<0.0001) and right putamen (p<0.0001). In the caudate, regional
shape differences were seen in both left and right caudates (figure 4), with the most
significant findings occurring in the caudate head. In the left putamen, significant changes
were seen in the dorsolateral and ventral regions, and in the right putamen in the area of the
dorsomedial and lateral regions (figure 5). There was no significant correlation between
duration of illness and changes in the caudate (figure 6) or the putamen (figure 7).
4. DISCUSSION
We have corroborated and extended the findings of two previous studies examining striatal
volume in ChAc (Henkel et al. 2006; Huppertz et al. 2008), demonstrating in the largest
cohort to date that both caudate and putaminal volumes are markedly reduced bilaterally in
ChAc. This reduction in volume was greater for the caudate nuclei than for the putamen.
Additionally, we showed that there was a significant morphometric difference for both
structures between controls and ChAc cases, suggesting that each structure is not uniformly
reduced. Significance maps showed that this was most notable for the head of the caudate
nucleus, and for the dorsal aspect of the putamen.
The original VBM study suggested that volumetric reductions were confined to the head of
the caudate nucleus in a small cohort of 6 ChAc patients compared to 15 controls(Henkel et
al. 2006). We showed that caudate changes occurred in other regions beyond the head,
including the tail. Our findings showing marked putaminal changes contrast to those of one
other study using regional volumetry, which showed significant, but less marked, volumetric
reductions in the putamen in ChAc(Huppertz et al. 2008). The lack of detection of reduction
beyond the caudate head and in the putamen in a VBM-style approach may indicate an
under-powered sample size (Whitwell 2009).
The study by Huppertz et al used similar VBM-style principles to the Henkel et al study, and
compared a larger cohort of 9 ChAc patients to 257 controls. In this study all subjects’
brains were normalised to a standard template, and then multiplied by a binary mask created
by manual tracing of caudate and putamen on each side of a normalised average of a further
120 controls, to result in volume measures. Whilst this approach addressed the power issue
inherent in the original study by use of a very large, presumably unmatched, healthy control
sample, this method again presumes accurate registration of subcortical structures and that
the whole putamen and caudate in each subject is contained within the grey matter mask.
Nonetheless, the results of the current study are similar in the degree of volumetric reduction
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observed in the Huppertz et al. (2008) cohort, and we showed a similar separation of patients
from controls. This may be, in part, due to the overlap between our sample and the sample
analysed in these two studies. The lack of a correlation between duration of illness in our
cohort however is notable, and may be indicative of the relatively reduced spread of
volumes in ChAc, or reflect the difficulty in ascertaining onset of illness when this may be
related to psychiatric as well as neurologic symptom onset (Walterfang et al. 2008).
Alternatively, it is possible that much of the neuron loss has already occurred at the time of
illness onset (Huppertz et al. 2008). This can be contrasted to the findings in the McLeod
disease study which showed striatal volume loss occurring with illness progression (Valko et
al. 2010).
Shape analysis of the caudate nucleus suggested a dorsal to ventral gradient of atrophy,
combined with a caudal to rostral pattern of atrophy in patients with ChAc. These changes
appear more pronounced on the left, although direct side-to-side comparisons of shape were
not undertaken. A dorsal-ventral pattern of atrophy has been previously described in
Huntington’s disease (Douaud et al. 2006), and suggests that ChAc shares a pattern of
atrophy with other neurodegenerative diseases affecting the caudate nucleus. The marked
loss of neurons in the tail of the caudate nucleus may be a reflection of the relative thinness
of this section in the normal state, such that a moderate loss of neurons in this region would
result in a marked apparent reduction and “foreshortening” of the caudate. The significantly
affected regions of the rostral aspect of the left caudate nucleus receive inputs from the
dorsolateral prefrontal cortex (DLPFC), anterior cingulate/medial prefrontal (ACC) and
rostral motor cortex. The affected regions of the caudal left caudate nucleus receive inputs
from the premotor, DLPFC and orbitofrontal (OFC) cortex (Draganski et al. 2008; Haber
2003; Haber et al. 2000; Leh et al. 2007; Utter and Basso 2008). For the rostral aspect of the
right caudate nucleus, similar regions are involved as for the left, but to a lesser extent,
whilst little caudal involvement is evident.
The putamen demonstrated a caudal to rostral pattern of atrophy in patients with ChAc, with
atrophy greatest at the caudal end of the putamen on both sides. There is little evidence of a
dorsal to ventral pattern of atrophy, as found in the caudate. As for the caudate nucleus, the
left putamen shows a greater differential change than the right. As there was an interaction
between group and side for these structures on measures of absolute volume, this suggests
that shape rather than volume changes may be greater on the left side. Similar to the caudate
nucleus, the putamen showed atrophy in regions receiving projections from DLPFC, ACC
and OFC (Haber 2003). The relative caudal atrophy of the putamen occurs in regions
receiving inputs from the premotor and motor cortex and the somatosensory and
supplementary motor cortex.
The atrophy described indicates potential widespread disruption of all three major
frontostriatal circuits (involving the DLPFC, ACC, and OFC regions(Draganski et al. 2008;
Haber 2003; Haber et al. 2000; Leh et al. 2007; Utter and Basso 2008)) relevant to
behaviour and cognition (Bonelli and Cummings 2007; Tekin and Cummings 2002). These
findings provide a structural basis for the clinical features of ChAc, where the most common
neuropsychiatric presentation is of behavioural change consistent with a dysexecutive
syndrome seen in more than 50% of cases, and the frequent presentation of OCD(Hardie et
al. 1991; Walterfang et al. 2008).
Limitations
Because of the exceptional rarity of the disorder, it was necessary to acquire scans from
different centres to facilitate analysis. Whilst all were scanned at 1.5T field strength and the
majority of scans utilised SPGR sequences, scanner make differed amongst subjects,
although had no effect on regional striatal volume.
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Whilst the nature of our shape analysis is suggestive of a particular pattern of atrophy,
particularly affecting the caudate head and with greater shape changes suggested on the left,
it is possible that the shape changes we see are a reflection of process that occurs relatively
uniformly across the structure. Given that the caudate is a C-shaped structure with a bulbous
head and long sweeping tail, a marked uniform loss of volume due to cell death and gliosis
may result in a structure with a more uniform thickness than that seen in healthy controls.
Only longitudinal studies, ideally from an early or presymptomatic stage, would be able to
resolve these two possibilities, to confirm whether at different illness stages differing
neuronal populations are more vulnerable to disruption of normal chorein function.
5. CONCLUSION
We have corroborated previous findings suggesting a marked loss of volume in the caudate
nucleus and putamen that allows almost complete separation from healthy matched controls
on volumetric measures. Clear shape differences were present in ChAc patients compared to
controls, suggestive of a predilection for neuronal loss of the head of the caudate nucleus.
This may correlate with the findings of very high rates of dysexecutive syndromes and
obsessive-compulsive symptomatology in this disorder. A lack of relationship with duration
of illness in a cohort of symptomatic patients suggests that a significant volumetric loss may
occur presymptomatically. We suggest that prospective, longitudinal studies be conducted to
investigate morphometric change of the striatum over the course of the illness.
Contemporaneous collection of neuropsychological and clinical data will allow examination
of correlations of such morphometry with clinical features, enhancing our understanding of
the pathophysiology of ChAc.
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Representation of orientation of caudate (red) and putamen (blue) shapes on coronal, sagittal
and horizontal view of a healthy control brain.
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Scatter-plot of left and right caudate volumes (left) and Z-scores (right) according to group,
showing significant separation of diagnostic groups and tight relationship between
contralateral volumes.
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Scatter plot of left and right putaminal volumes (left) and Z-scores (right) according to
group, showing significant separation, but greater left-right variation in the control group.
Walterfang et al. Page 12














Left (top) and right (bottom) caudate changes, showing differences between ChAc patients
and controls. On left, uncorrected raw p-value map; middle, FDR-corrected p-value map;
right, between-group displacement map. Legend to p-value map shows that regions with
p>0.05 are coloured blue, with significant values on a spectrum from green (p=0.05) to red
(p=0). Legend to displacement map shows displacement of ChAc group from control group
in mm.
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Left (top) and right (bottom) putamen changes, showing differences between ChAc patients
and controls.
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Significance maps of correlations between duration of illness and shape of left (top) and
right (bottom) caudates, showing uncorrected p-value maps (left), with FDR-corrected maps
(middle) and Spearman’s r map (right). Legend to p-value map shows that regions with
p>0.05 are coloured blue, with significant values on a spectrum from green (p=0.05) to red
(p=0).
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Significance maps of correlations between duration of illness and shape of left (top) and
right (bottom) putamen, showing uncorrected p-value maps (left), with FDR-corrected maps
(middle) and Spearman’s r map (right). Legend to p-value map shows that regions with
p>0.05 are coloured blue, with significant values on a spectrum from green (p=0.05) to red
(p=0).
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Table 1
Demographic and symptom data of ChAc group. Patients 1–7 correspond with patients 1–7 from (Huppertz et
al. 2008). Patient 9 was described in (Robertson et al. 2008) and patient 11 in (Rodrigues et al. 2008).
Age at scan Gender Disease Duration (years) Diagnostic Method*
P1 30 F 6 VPS13A
P2 42 M 18 VPS13A
P3 35 M 8 VPS13A
P4 26 M 6 VPS13A
P5 36 M 7 VPS13A
P6 40 F 18 VPS13A
P7 44 M 7 VPS13A
P8 36 M 5 Chorein
P9 38 F 17 Chorein
P10 40 M 11 Chorein
P11 59 F 30 Chorein
P12 42 F 9 Chorein
P13 46 F 12 Chorein
39.07±7.92 (7M/6F) 12.57±6.87
*
”VPS13A” indicates that mutation was found on genetic screening. “Chorein” indicates that diagnosis was made by Western blot.
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Table 2
Between-group comparisons on demographic and intracranial variables.
Patients Controls t/F(df) p
Age (yrs) 38.02 ± 6.94 39.07 ± 7.92 −0.418 0.680
Gender (M/F) 7/6 14/12 - -
Intracranial volume (x103 mm3) 1478 ± 146 1594 ± 233 −1.692 0.107
Left Caudate volume (mm3) 1527 ± 499 4344 ± 573 154.51(38) <0.0001
Right Caudate volume (mm3) 1547 ± 549 4360 ± 542 152.09 (38) <0.0001
Left Putamen volume (mm3) 1631 ± 649 3913 ± 616 78.36 (38) <0.0001
Right Putamen volume (mm3) 1703 ± 730 3945 ± 672 58.13 (38) <0.0001
t = value of t-statistic. F = value of F statistic where df = degrees of freedom.
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